McDermott Will & Emery Advises Sensorion on its New Financing - McDermott Will & Emery

McDermott Will & Emery Advises Sensorion on its New Financing


McDermott Will & Emery has advised Sensorion, a pioneering clinical-stage biotechnology company specializing on the development of new therapies to restore, treat and prevent hearing loss disorders, on its new financing of over EUR 50 million from existing and new investors specializing in the healthcare sector.

McDermott advised Sensorion in August 2023 on its EUR 35 million financing through the issue of ordinary shares and pre-funded warrants.

The team advising Sensorion included :

  • Bertrand Delafaye, Emmanuelle Trombe, partners, Henri Nalbandyan and Claire Chabat, associates, on corporate aspects
  • Antoine Vergnat, partner, on tax law aspects

About McDermott

McDermott Will & Emery partners with leaders around the world to fuel missions, knock down barriers and shape markets. Our team works seamlessly across practices and industries to deliver highly effective solutions that propel success. More than 1,400 lawyers strong, we bring our personal passion and legal prowess to bear in every matter for our clients and the people they serve.